Answers are grounded in this paper and cite their sources.
Aim: This study was to histologically assess the therapeutic effect of aqueous fruit extract of Phoenix dactylifera (AFEPD) on lead acetate-induced cerebellar damage in Wistar rats. Methods: Twenty four rats were grouped into six (I–VI; n=4). Group I (control) received distilled water (1 ml/kg). Group II received lead acetate (LA, 120mg/kg) only. Groups III and IV received LA (120mg/kg) followed by AFEPD (1000mg/kg and 1500mg/kg, respectively). Groups V and VI received AFEPD (1000mg/kg and 1500mg/kg, respectively). All administrations were by oral route. Treatment lasted 28 days; LA was administered from day 1 to day 14, while AFEPD was administered from day 15 to day 28 of the experimental period. Therapeutic activity of AFEPD was assessed by histological examination of the cerebellar cortex with H and E stain. Results: Findings revealed neurodegenerative changes in the cerebellar cortex like perineuronal vacoulations and cytoplasmic shrinkage in molecular layer cells and Purkinje cells in LA-intoxicated group. The administration of AFEPD remarkably ameliorated LA–induced cerebellar damage dose dependently. Normal cerebellar histoarchitecture was observed with administration of AFEPD only. Conclusion: Results suggest that AFEPD has therapeutic potentials against lead acetate-induced cerebellar damage in Wistar rats.
No takes yet. Share an insight, caveat, or question.
Yusuf et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: